Shewalton Road Riverside Business Park Irvine Ayrshire, Strathclyde
GlaxoSmithKline Wind Project is a 7.5 MW onshore wind project in Scotland. The applicant or operator on record is Glaxosmithkline. It is recorded as operational since June 2013. The determining authority is North Ayrshire, reference 09/00878/PP.β¦
OperationalΒ· Since 2013
Project stageOperating
PlanningJan 2010 (completed)
ConsentedMay 2012 (completed)
Construction (completed)
OperatingJun 2013 (current stage)
Closed (not yet reached)
Status in the official register: Operational.
Official register: July 2026
Recorded status: Operational. Source record updated 2013-10-03.
Registered planning capacity; not measured generation.
GlaxoSmithKline Wind Project is a 7.5 MW onshore wind project in Scotland. The applicant or operator on record is Glaxosmithkline. It is recorded as operational since June 2013. The determining authority is North Ayrshire, reference 09/00878/PP.
Site Schematic
Schematic diagram β not to scale. Illustrative layout based on project specifications.
π§ Technical Specifications
Capacity (MW)
7.500 MW
π Grid Connection & Infrastructure
π’ Development & Ownership
Developer
Glaxosmithkline
Owner / operator
Glaxosmithkline
Year consented
2012
Commissioned / target
2013
Location
Shewalton Road Riverside Business Park Irvine Ayrshire, Strathclyde